Marina Caskey, MD
Enriched profileProfessor of Clinical Investigation, The Rockefeller University; Adjunct Assistant Professor of Clinical Medicine in the Division of Infectious Diseases, Weill Cornell Medical College; Attending Physician, NewYork-Presbyterian Hospital · The Rockefeller University
Marina Caskey is Professor of Clinical Investigation, The Rockefeller University; Adjunct Assistant Professor of Clinical Medicine in the Division of Infectious Diseases, Weill Cornell Medical College; Attending Physician, NewYork-Presbyterian Hospital at The Rockefeller University. OpenAlex indexes 153 publications with 21,646 citations (h-index 64); ClinicalTrials.gov lists 18 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 24 Oct 2026
Marina Caskey, M.D., is Professor of Clinical Investigation, The Rockefeller University. The public record shows 153 publications with 21,646 citations (h-index 64), centered on HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 4 companies, 9 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2026 · Nature medicine
- Top research focus: HIV Research and Treatment
- 18 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 34 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 103.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 24 Oct 2026
Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:
- HepB mAb19 in Individuals With Chronic Hepatitis B Infection
Sponsor: Rockefeller University
- 3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)
Sponsor: Rockefeller University
- Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
Updated 24 Oct 2026
4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20255 payments
- ViiV Healthcare CompanyProgram year20251 payment
- Gilead Sciences, Inc.Program year20251 payment
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor100%Emtricitabine-Tenofovir Disop100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 24 Oct 2026
9 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- REACH: Research Enterprise to Advance a Cure for HIV
Weill Medical Coll of Cornell Univ
FY2026$5,414,805UM1AI164565 - INSPIRE: Innovative Strategies for Personalized Immunotherapies and Reservoir Eradication
Weill Medical Coll of Cornell Univ
FY2026$2,915,052UM1AI191237 - Defining the mechanisms of HIV resistance to bNAbs in humans
Rockefeller University
FY2026$1,569,774U01AI169385
Publications
Updated 24 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- What's Hot in HIV in 2025-A Basic and Translational Science Review From IDWeek 2025.
The Journal of infectious diseases
Review2026 - Diverse paths to broadly neutralizing antibody escape among HIV-1 strains.
Nature microbiology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Convergent antibody responses to SARS-CoV-2 in convalescent individualsArticle1,850 citations2020
- 02Evolution of antibody immunity to SARS-CoV-2Article1,665 citations2021
- 03mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsArticle1,340 citations2021
- 04Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantsArticle1,308 citations2020
- 05
Network
Updated 24 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 24 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
rockefeller.edu/our-scientists/research-affiliates/5615-marina-caskey
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rockefeller.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 24 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
Editorial & leadership roles
journal and society appointments- Elected Member
American Society of Clinical Investigation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗
Secondary affiliations
appointments beyond the home institution- Weill Cornell Medicine
Division of Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital